Not yet recruiting NCT06054191
Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations
NSCLC · BRAF V600 Mutation · MET Exon 14 Mutation
Lung cancer
3,760 trials in this section
Recruiting NCT05241028
Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Recruiting NCT05724004
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
Radiotherapy Side Effect · Non-small Cell Lung Cancer · ALK Gene Mutation
Not yet recruiting NCT06067776
Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer
Metastatic Lung Non-Small Cell Carcinoma · Recurrent Lung Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
Recruiting NCT05502913
Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
Metastatic Lung Cancer
Recruiting NCT04631770
Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC
Lung Neoplasms · Lymph Node Excision
Recruiting NCT06056115
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
Lung Adenocarcinoma
Not yet recruiting NCT06057194
Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.
Infections, Cytomegalovirus
Recruiting NCT05999214
99mTc-H7ND SPECT/CT Imaging in NSCLC
NSCLC
Recruiting NCT06041776
Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations
Non-Small Cell Lung Cancer · EGFR Sensitive Mutation · Adjuvant Therapy
Recruiting NCT06050980
Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation
NSCLC
Not yet recruiting NCT06018688
Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.
Non Small Cell Lung Cancer · EGFR Gene Mutation
Recruiting NCT05732974
A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
Non-small Cell Lung Cancer Stage IIIA
Recruiting NCT06043973
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
Advanced Non-small Cell Lung Cancer
Not yet recruiting NCT06048315
A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody
Lung Cancer · TKI Resistance · EGFR Sensitive Mutation
Recruiting NCT05526950
Cytokine Filtration in Lung Transplantation: A Swedish National Study (GLUSorb)
Lung Transplant Failure · Lung Transplant; Complications
Recruiting NCT04728724
Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer
Non-small Cell Lung Cancer Stage III
Not yet recruiting NCT06028633
Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients
Advanced Non-squamous Non-small-cell Lung Cancer · Recurrent Non-Squamous Non-Small Cell Lung Cancer · Metastatic Non-squamous Non Small Cell Lung Cancer
Recruiting NCT06031246
Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)
Lung Adenocarcinoma · Lymph Node Metastasis
Recruiting NCT03742687
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
Stage III Non-small-cell Lung Cancer · Stage IV Non-small Cell Lung Cancer · Radiotherapy Side Effect
Not yet recruiting NCT06029543
Permian Health Women's Lung Health Study
COPD · Lung Function Decreased · Alpha 1-Antitrypsin
Recruiting NCT06026735
Non-small Cell Lung Cancer With Central Nervous System Metastasis
Lung Cancer With Central Nervous System Metastasis
Recruiting NCT05860387
Early Diagnosis of Invasive Lung Aspergillosis
Respiratory Infection · Invasive Pulmonary Aspergillosis
Recruiting NCT05699213
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
Lung Cancer
Recruiting NCT05841472
Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non Squamous Non Small Cell Lung Cancer
Not yet recruiting NCT06015568
Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation
Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
Not yet recruiting NCT05998993
Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)
EGF-R Positive Non-Small Cell Lung Cancer · Non Small Cell Lung Cancer · EGFR Exon 19 Deletion
Recruiting NCT06001151
Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCLC) Patients With Programmed Cell Death Ligand 1 (PD-L1) Negative
Carcinoma, Non-Small-Cell Lung
Not yet recruiting NCT05990127
A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer
Locally Advanced or Metastatic NSCLC
Recruiting NCT00951366
Preterm Lung Patient Registry
Bronchopulmonary Disease
Recruiting NCT05623267
Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Limited Stage Small Cell Lung Cancer
Recruiting NCT05838053
Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Lung Adenocarcinoma
Recruiting NCT03786003
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
Carcinoma, Non-Small-Cell Lung
Recruiting NCT05837052
A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC
Unresectable Lung Non-Small Cell Carcinoma
Not yet recruiting NCT05940116
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors
Non-Small Cell Lung Cancer · Solid Tumor
Recruiting NCT05940532
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
Carcinoma, Non-Small-Cell Lung
Recruiting NCT05934032
National Network Genomic Medicine Lung Cancer, Germany
Carcinoma, Non-Small-Cell Lung
Recruiting NCT05926713
Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease
Sarcopenia · COPD · ILD
Recruiting NCT05913089
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
Non Small Cell Lung Cancer
Not yet recruiting NCT05802654
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
Early Lung Cancer · Stereotactic Body Radiotherapy
Recruiting NCT05432739
Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study
Lung Cancer
Not yet recruiting NCT05904015
The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC
Lung Neoplasms
Recruiting NCT05857800
Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment
Lung Cancer
Not yet recruiting NCT05891080
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial
Stage III Non-small Cell Lung Cancer
Not yet recruiting NCT05881057
Application of SERS Technology Based Intraoperative Navigation System in Lung Cancer
Lung Cancer
Recruiting NCT05663242
The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action
Lung Cancer · Progression, Disease · Anesthesia
Not yet recruiting NCT05496166
The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer
Limited Stage Small Cell Lung Cancer
Recruiting NCT05586906
Noninvasive Early Detection of Lung Allograft Dysfunction After Lung Transplantation With Multiple Breath Washout Test
Chronic Rejection of Lung Transplant
Recruiting NCT05778708
Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients
Advanced Lung Non-Small Cell Carcinoma
Enrolling by invitation NCT05851755
Italian Lung Cancer Observational Study
Lung Cancer
Recruiting NCT04539977
PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer
Small-cell Lung Cancer
Recruiting NCT02448992
Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer
Non-Small-Cell Lung Cancer (NSCLC) · Brain Metastasis
Recruiting NCT05825443
Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients
Immunotherapy · Chemotherapy
Not yet recruiting NCT05822284
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy
Non-small Cell Lung Cancer
Recruiting NCT05271916
First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations
Non-Small Cell Lung Cancer (NSCLC)
Recruiting NCT01994057
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
Non-small Cell Lung Cancer (NSCLC) · EGFR-TKI Resistant Mutation · EGFR-TKI Sensitizing Mutation
Not yet recruiting NCT05808790
Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy
Lung Metastases · Colorectal Cancer Metastatic
Recruiting NCT05800340
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
Non-Small Cell Lung Cancer · RET Driver Mutation · BRAF V600 Mutation
Recruiting NCT05800223
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
Non-small Cell Lung Cancer Metastatic
Not yet recruiting NCT05767892
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recruiting NCT05797493
Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer
Small Cell Lung Cancer
Not yet recruiting NCT05784974
Cadonilimab Monotherapy as Neoadjuvant Therapy for Resectable II-IIIA Squamous Cell Lung Cancer
Lung Cancer
Recruiting NCT01789229
Establishment of a Tumor Bank for Tissue Samples
Ovarian Neoplasms · Breast Neoplasms · Colorectal Neoplasms
Recruiting NCT01763125
Establishment of a Tumor Bank for Blood Samples
Ovarian Neoplasms · Breast Neoplasms · Colorectal Neoplasms
Recruiting NCT05778253
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
Lung Squamous Cell Carcinoma
Not yet recruiting NCT05778149
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation
Aumolertinib · Anlotinib · TP53
Recruiting NCT05286957
MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC
NSCLC
Not yet recruiting NCT05698238
Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours
Clear Cell Renal Cell Carcinoma Metastatic · TNBC - Triple-Negative Breast Cancer · Head and Neck Cancer
Recruiting NCT05768490
Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases
Brain Metastases · Radiotherapy · EGFR Activating Mutation
Recruiting NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Advanced Biliary Tract Carcinoma · Advanced Colorectal Carcinoma · Advanced Gastroesophageal Junction Adenocarcinoma
Recruiting NCT05354596
A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).
Lung Cancer · Metastases to Lung · Radiotherapy Side Effect
Not yet recruiting NCT05745506
Effect of Sleep Disorder on the Development of Lung Tumors
Sleep Disorder, Lung Tumor
Recruiting NCT05736029
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
Non Small Cell Lung Cancer · Healthy
Not yet recruiting NCT05703997
FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction
Small Cell Lung Carcinoma
Not yet recruiting NCT05698264
A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC
Non Small Cell Lung Cancer · EGFR Gene Mutation · Immune Checkpoint Inhibitor
Recruiting NCT05686434
Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)
NSCLC, Stage I
Not yet recruiting NCT05676788
HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections
Lung Neoplasm · Pulmonary Metastasis
Recruiting NCT04677205
Molecular Signature From Tumor to Lymph Nodes
Lung Cancer · Stage IIIA-cN2 · Operated With Curative Intent
Recruiting NCT05596578
Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion
Lung Cancer · Lymph Node Metastasis
Recruiting NCT05537922
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
Non Small Cell Lung Cancer · Lung Cancer Metastatic · Lung Cancer, Nonsmall Cell
Recruiting NCT05636605
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
Lung Cancer
Recruiting NCT05429463
Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）
Squamous Cell Non-small Cell Lung Cancer
Recruiting NCT05486455
Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
Smoking
Recruiting NCT05627960
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Triple Negative Breast Cancer · Hormone-Resistant Breast Cancer · Non Small Cell Lung Cancer
Recruiting NCT04720339
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
NSCLC · IMMUNOTHERAPY · QUANTIFICATION OF CELL-FREE DNA
Not yet recruiting NCT05621902
Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer
Lung Cancer
Recruiting NCT04451473
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
Lung Cancer · Surgery · ERAS
Not yet recruiting NCT05597800
Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome
NSCLC Stage IV · HIV · HBV
Not yet recruiting NCT05548504
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
Non-small Cell Lung Cancer Stage III · Radiotherapy Side Effect · Frailty
Recruiting NCT02852928
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Lung Diseases, Interstitial · Pulmonary Alveolar Proteinosis · Pulmonary Eosinophilia
Recruiting NCT05536505
Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
MRD
Recruiting NCT05339568
Patient's Whole Process Follow-up Management(HOPE-1)
Locally Advanced Non-Small Cell Lung Cancer · Metastatic NSCLC
Recruiting NCT05334277
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
Non-small Cell Lung Cancer
Recruiting NCT04996121
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic Solid Tumors · Locally Advanced or Metastatic Non-small Cell Lung Cancer
Recruiting NCT04875585
Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC
Non Small Cell Lung Cancer
Recruiting NCT05503667
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
Lung Adenocarcinoma Stage III · Lung Adenocarcinoma Stage IV · EGFR Gene Mutation
Not yet recruiting NCT05503888
Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer
Relapsed or Advanced Non-small Cell Lung Cancer
Recruiting NCT04926584
Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option
Carcinoma, Non-Small-Cell Lung
Recruiting NCT05494021
China Lung Cancer Screening (CLUS) Study Version 3.0
Lung Cancer
Not yet recruiting NCT05484583
Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases
Lung Cancer · Extensive-stage Small-cell Lung Cancer · Radiotherapy